Abstract
Electromotive drug administration (EMDA) is a method of increasing the transport of drugs across barriers by means of an electric current. In patients with Peyronie’s disease, EMDA of verapamil into the tunica albuginea provides measurable drug levels in plaque tissue. Four clinical studies using different methods showed that EMDA of verapamil and dexamethasone is a safe and effective treatment for Peyronie’s disease, reducing plaque volume, penile deviation, and pain, and can contribute to the improvement in erectile capacity and sexual function.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gholami SS, Lue TF. Peyronie’s disease. Urol Clin North Am 2001; 28: 377–390.
Hellstrom WJ, Bivalacqua TJ. Peyronie’s disease: etiology, medical, and surgical therapy. J Androl 2000; 21: 347–354.
Levine LA, Goldman KE, Greenfield JM. Experience with intraplaque injection of verapamil for Peyronie’s disease. J Urol 2002; 168: 621–625.
Martin DJ, Badwan K, Parker M, Mulhall JP. Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea. J Urol 2002; 168: 2483–2485.
Rothfeld SH, Murray W. The treatment of Peyronie’ s disease by iontophoresis of C21 esterified glucocorticoids. J Urol 1967; 97: 874–875.
Kahn J. Use of iontophoresis in Peyronie’s disease. A case report. Phys Ther 1982; 62: 995–996.
Fishman IJ, Wong HY, Griffith DP. Case report. Iontophoretic delivery of steroids in the treatment of Peyronie’s disease: case reports of three successful outcomes. Minim Invasive Ther 1994; 3: 121–122.
Levine LA, Estrada CR, Shou W, Cole A. Tunica albuginea tissue analysis after electromotive drug administration. J Urol 2003; 169: 1775–1778.
Riedl CR, Plas E, Engelhardt P, Daha K, Pflüger H. Iontophoresis for treatment of Peyronie’s disease. J Urol 2000; 163:95–99.
Montorsi F, Salonia A, Guazzino G, et al. Transdermal electromotive multi-drug administration for Peyronie’s disease: preliminary results. J Androl 2000; 21: 85–90.
Di Stasi SM, Giannantoni A, Capelli G, et al. Transdermal electromotive administration of verapamil and dexamethasone for Peyronie’s disease. BJU Int 2003; 91: 825–829.
Di Stasi SM, Giannantoni A, Stephen R, et al. Prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie’s disease. J Urol 2004; 171: 1605–1608.
Bellantone NH, Rim S, Francoeur ML, Rosadi B. Enhanced percutaneous absorption via iontophoresis. Evaluation of an in vitro system and transport of model compounds. Int J Pharm 1986; 30: 63–72.
Banga AK, Chien YW. Iontophoretic delivery of drugs: fundamentals, developments and biomedical applications. J Controlled Release 1988; 7: 1–24.
Glass JM, Stephen RL, Jacobson CJ. The quality and distribution of radiolabeled dexamethasone delivered to tissue by iontophoresis. Int J Dermatol 1980; 19: 519–525.
Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin: mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 1993; 90: 10,504–10,508.
Stephen RL, Miotti D, Bettoglio R, Rossi C, Bonezzi C. Electromotive administration of a new morphine formulation: morphine citrate. Artif Organs 1994; 18: 461–465.
Greenfield JM, Shah SJ, Levine LA. Verapamil vs saline in electromotive drug administration (EMDA) for Peyronie’ s disease: a double-blind placebo-controlled trial. Presented at the Fall 2005 meeting of the Sexual Medicine Society of North America, New York City.
Ojigwa JC, Isseroff RR. Electrical stimulation of wound healing. J Invest Dermatol 2002; 36: 1–12.
Roth M, Eickelberg O, Kohler E, Erne P, Block LH. Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proc Natl Acad Sci USA 1996; 93: 5478–5482.
Anderson MS, Shankey TV, Lubrano T, Mulhall JP. Inhibition of Peyronie’s plaque fibroblast proliferation by biologic agents. Int J Impot Res 2000; 3(suppl): S25.
Petelenz TJ, Buttke JA, Bonds C, et al. Iontophoresis of dexamethasone: laboratory studies. J Controlled Release 1992; 7: 141–145.
Levine LA, Sevier VL. A double-blind, placebo-controlled trial of electromotive drug administration (EMDA) using verapamil vs saline for Peyronie’s disease: preliminary results. J Urol 2003; 169(suppl): 274. Abstract 1066.
Hellstrom W, Eichelberg C, Pryor JL, et al. A single-blind, multi-center, placebo-controlled study to assess the safety and efficacy of intralesional interferon α-2b in the non-surgical treatment of Peyronie’s disease. J Urol 2003; 169(suppl): 274. Abstract 1065.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Di Stasi, S.M. et al. (2007). Topical Therapy. In: Levine, L.A. (eds) Peyronie’S Disease. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-59745-161-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-59745-161-1_8
Publisher Name: Humana Press
Print ISBN: 978-1-58829-614-6
Online ISBN: 978-1-59745-161-1
eBook Packages: MedicineMedicine (R0)